BioLineRx (BLRX) Total Non-Current Liabilities (2010 - 2026)
BioLineRx's Total Non-Current Liabilities was $3.18 million in the quarter ended Jun 30, 2026, down 58.8% from $7.72 million a year earlier and down 26.6% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, Total Non-Current Liabilities at BioLineRx came in at $5.44 million, down 45.8% from the prior year.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of -17.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Total Non-Current Liabilities was $10.04 million in the year ended Dec 31, 2024 (+26.8%), $7.92 million in the year ended Dec 31, 2023 (+462.4%), $1.41 million in the year ended Dec 31, 2022 (+44.4%) and $975,000 in the year ended Dec 31, 2021 (-93.3%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Non-Current Liabilities since the quarter ended Dec 31, 2022.
- Compared with a year earlier, Total Non-Current Liabilities has declined for five straight quarters, with an average decline of 32.2% over the last eight quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was the quarter ended Mar 31, 2023 (growth of 673.3%); the worst was the quarter ended Dec 31, 2021 (a decline of 93.3%).
- Per Business Quant data, BLRX's Total Non-Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $4.34 million (quarter ended Mar 31, 2026), $5.44 million (quarter ended Dec 31, 2025) and $6.6 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | BioLineRx | 9.10 Mn | -67.42 Mn | 235,000.00 | 3.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.18 Mn |
| Mar 31, 2026 | 4.34 Mn |
| Dec 31, 2025 | 5.44 Mn |
| Sep 30, 2025 | 6.60 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Mar 31, 2025 | 8.62 Mn |
| Dec 31, 2024 | 10.04 Mn |
| Sep 30, 2024 | 19.28 Mn |
| Jun 30, 2024 | 20.10 Mn |
| Mar 31, 2024 | 7.17 Mn |
| Dec 31, 2023 | 7.92 Mn |
| Sep 30, 2023 | 25.00 Mn |
| Jun 30, 2023 | 25.44 Mn |
| Mar 31, 2023 | 17.49 Mn |
| Dec 31, 2022 | 14.86 Mn |
| Sep 30, 2022 | 18.02 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Dec 31, 2021 | 3.59 Mn |
| Sep 30, 2021 | 5.69 Mn |
API Access
BioLineRx Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();